These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

328 related items for PubMed ID: 18180005

  • 1. Nephrogenic systemic fibrosis: an overview.
    Cowper SE.
    J Am Coll Radiol; 2008 Jan; 5(1):23-8. PubMed ID: 18180005
    [Abstract] [Full Text] [Related]

  • 2. Nephrogenic systemic fibrosis: a dermatologist's perspective.
    Girardi M.
    J Am Coll Radiol; 2008 Jan; 5(1):40-4. PubMed ID: 18180008
    [Abstract] [Full Text] [Related]

  • 3. Impact on hospital policy: Yale experience.
    Weinreb JC.
    J Am Coll Radiol; 2008 Jan; 5(1):53-6. PubMed ID: 18180010
    [Abstract] [Full Text] [Related]

  • 4. Circulating fibrocytes: cellular basis for NSF.
    Bucala R.
    J Am Coll Radiol; 2008 Jan; 5(1):36-9. PubMed ID: 18180007
    [Abstract] [Full Text] [Related]

  • 5. Introduction to this issue on NSF.
    Weinreb JC.
    J Am Coll Radiol; 2008 Jan; 5(1):21-2. PubMed ID: 18180004
    [No Abstract] [Full Text] [Related]

  • 6. Safety update on the possible causal relationship between gadolinium-containing MRI agents and nephrogenic systemic fibrosis.
    Pedersen M.
    J Magn Reson Imaging; 2007 May; 25(5):881-3. PubMed ID: 17457808
    [No Abstract] [Full Text] [Related]

  • 7. Gadolinium-induced nephrogenic systemic fibrosis in patients with kidney and liver disease.
    Shenoy C.
    Am J Med; 2008 Jan; 121(1):e11; author reply e13. PubMed ID: 18187056
    [No Abstract] [Full Text] [Related]

  • 8. Tissue distribution and kinetics of gadolinium and nephrogenic systemic fibrosis.
    Abraham JL, Thakral C.
    Eur J Radiol; 2008 May; 66(2):200-7. PubMed ID: 18374532
    [Abstract] [Full Text] [Related]

  • 9. Clinical and histological findings in nephrogenic systemic fibrosis.
    Cowper SE, Rabach M, Girardi M.
    Eur J Radiol; 2008 May; 66(2):191-9. PubMed ID: 18325705
    [Abstract] [Full Text] [Related]

  • 10. [Nephrogenic systemic fibrosis possibly caused by gadolinium-containing contrast agent].
    van der Meij N, Keur I, van Lienden KP, Scheepstra CG, Bos JD.
    Ned Tijdschr Geneeskd; 2007 Dec 29; 151(52):2898-903. PubMed ID: 18257437
    [Abstract] [Full Text] [Related]

  • 11. Gadolinium-containing MRI contrast agents: important variations on a theme for NSF.
    Kuo PH.
    J Am Coll Radiol; 2008 Jan 29; 5(1):29-35. PubMed ID: 18180006
    [Abstract] [Full Text] [Related]

  • 12. The impact of NSF on the care of patients with kidney disease.
    Abu-Alfa A.
    J Am Coll Radiol; 2008 Jan 29; 5(1):45-52. PubMed ID: 18180009
    [Abstract] [Full Text] [Related]

  • 13. Nephrogenic systemic fibrosis: experimental studies confound prevailing theory of free gadolinium as a causative factor.
    Jakobsen J.
    Acta Radiol; 2008 Jul 29; 49(6):616-7. PubMed ID: 18568551
    [No Abstract] [Full Text] [Related]

  • 14. Nephrogenic fibrosing dermopathy/nephrogenic systemic fibrosis.
    Hamilton-Persaud K, Ezell LD, Macklin JG.
    Nephrol Nurs J; 2007 Jul 29; 34(3):283-7; quiz 288. PubMed ID: 17644872
    [Abstract] [Full Text] [Related]

  • 15. On the potential causal relationship between gadolinium-containing MRI agents and nephrogenic systemic fibrosis.
    Partain CL.
    J Magn Reson Imaging; 2007 May 29; 25(5):879-80. PubMed ID: 17457806
    [No Abstract] [Full Text] [Related]

  • 16. Nephrogenic systemic fibrosis: a serious iatrogenic disease of renal failure patients.
    Khurram M, Skov L, Rossen K, Thomsen HS, Marckmann P.
    Scand J Urol Nephrol; 2007 May 29; 41(6):565-6. PubMed ID: 17934986
    [Abstract] [Full Text] [Related]

  • 17. Nephrogenic systemic fibrosis: is gadolinium the missing piece to the puzzle?
    Bennett LK, Garrett AL.
    Cutis; 2008 May 29; 81(5):421-6. PubMed ID: 18543594
    [Abstract] [Full Text] [Related]

  • 18. Gadolinium and nephrogenic systemic fibrosis: association or causation.
    Kurtkoti J, Snow T, Hiremagalur B.
    Nephrology (Carlton); 2008 Jun 29; 13(3):235-41. PubMed ID: 18221255
    [Abstract] [Full Text] [Related]

  • 19. Nephrogenic systemic fibrosis after exposure to gadolinium in patients with renal failure.
    Othersen JB, Maize JC, Woolson RF, Budisavljevic MN.
    Nephrol Dial Transplant; 2007 Nov 29; 22(11):3179-85. PubMed ID: 17890246
    [Abstract] [Full Text] [Related]

  • 20. Nephrogenic systemic fibrosis associated with liver transplantation, renal failure and gadolinium.
    Caccetta T, Chan JJ.
    Australas J Dermatol; 2008 Feb 29; 49(1):48-51. PubMed ID: 18186850
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.